Cargando…
A(2A)R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
Gliomas are considered one of the most malignant tumors in the body. The immune system has the ability to control the initiation and development of tumors, including gliomas. Thus, immune cells find themselves controlled by various molecular pathways, inhibiting their activation, such as the immunos...
Autores principales: | Rafii, Soumaya, Ghouzlani, Amina, Naji, Oumayma, Ait Ssi, Saadia, Kandoussi, Sarah, Lakhdar, Abdelhakim, Badou, Abdallah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095519/ https://www.ncbi.nlm.nih.gov/pubmed/37047660 http://dx.doi.org/10.3390/ijms24076688 |
Ejemplares similares
-
NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
por: Miftah, Hayat, et al.
Publicado: (2023) -
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
por: Rafii, Soumaya, et al.
Publicado: (2023) -
The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021) -
The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021)